<code id='EA495E936F'></code><style id='EA495E936F'></style>
    • <acronym id='EA495E936F'></acronym>
      <center id='EA495E936F'><center id='EA495E936F'><tfoot id='EA495E936F'></tfoot></center><abbr id='EA495E936F'><dir id='EA495E936F'><tfoot id='EA495E936F'></tfoot><noframes id='EA495E936F'>

    • <optgroup id='EA495E936F'><strike id='EA495E936F'><sup id='EA495E936F'></sup></strike><code id='EA495E936F'></code></optgroup>
        1. <b id='EA495E936F'><label id='EA495E936F'><select id='EA495E936F'><dt id='EA495E936F'><span id='EA495E936F'></span></dt></select></label></b><u id='EA495E936F'></u>
          <i id='EA495E936F'><strike id='EA495E936F'><tt id='EA495E936F'><pre id='EA495E936F'></pre></tt></strike></i>

          knowledge

          knowledge

          author:fashion    Page View:27928
          Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT
          Darron Cummings/AP

          The benefits and risks of Eli Lilly’s treatment for Alzheimer’s disease were confirmed in detailed scientific disclosures Monday, paving the way for its full approval but leaving physicians with lingering questions about the medicine’s impact on patients as a new era in Alzheimer’s therapy unfolds.

          The drug, called donanemab, showed a 35% slowing of Alzheimer’s disease progression relative to placebo in a clinical trial that enrolled 1,700 patients with early-stage disease. Numerically, that’s a modest, 3.3-point improvement on a 144-point survey, called the Integrated Alzheimer’s Disease Rating Scale, or iADRS, that combines measures of cognition and function, such as driving, managing finances, or carrying on conversations.

          advertisement

          There was a similar benefit when donanemab’s efficacy was assessed using a more common measure of cognition called the Clinical Dementia Rating-Sum of Boxes, or CDR-SB. On that scale, the Lilly drug showed a 36% slowing of cognitive decline relative to placebo, or 0.68 points on an 18-point scale.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more
          Here's how to stay safe from wildfire smoke amid reduced air quality
          Here's how to stay safe from wildfire smoke amid reduced air quality

          1:54ApersonwearingafacemaskwalksnearaviewofthetheEmpireStateBuildingduringheavysmoginNewYorkonJune6,

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Health tech startups drop sharply from 2021 highs

          AdobeInlessthantwoyears,digitalhealth’shigh-flyingclassofpublicdebutshavelandedwitharesoundingthud.A